| Literature DB >> 30455142 |
Jacobo Moreno Garijo1, Marcelo Cypel2, Karen McRae3, Tiago Machuca2, Valerie Cunningham4, Peter Slinger3.
Abstract
Lung transplantation has become an accepted therapy for most causes of end-stage lung disease. Between 30 to 50% of lung transplants require extracorporeal life support (ECLS). In many lung transplantation centers, extracorporeal membrane oxygenation (ECMO) is replacing cardiopulmonary bypass (CPB) as the primary choice for intraoperative ECLS. This review will discuss the evolving role of ECMO in lung transplantation and its implications for anesthetic management.Entities:
Keywords: cardiopulmonary bypass; extracorporeal life support; extracorporeal membrane oxygenation; lung transplantation
Mesh：
Substances：
Year: 2018 PMID： 30455142 DOI： 10.1053/j.jvca.2018.10.007
Source DB: PubMed Journal: J Cardiothorac Vasc Anesth ISSN： 1053-0770 Impact factor: 2.628